- Report
- October 2024
- 198 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- February 2025
- 200 Pages
Global
From €4268EUR$4,490USD£3,586GBP
- Report
- October 2024
- 199 Pages
Global
From €3370EUR$3,545USD£2,831GBP
€3745EUR$3,939USD£3,146GBP
- Report
- December 2021
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- August 2023
- 114 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- August 2022
- 110 Pages
Global
From €4516EUR$4,750USD£3,794GBP
- Report
- April 2023
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- January 2022
- 192 Pages
Global
From €3422EUR$3,600USD£2,875GBP
- Report
- January 2022
- 78 Pages
Middle East, Africa
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 78 Pages
Europe
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 68 Pages
North America
From €1426EUR$1,500USD£1,198GBP
- Report
- January 2022
- 78 Pages
Asia Pacific
From €1426EUR$1,500USD£1,198GBP
- Book
- March 2017
- 250 Pages

The Viral Specimen Collection market within the In Vitro Diagnostics (IVD) industry is a rapidly growing sector. It involves the collection of biological samples from patients for the purpose of testing for a variety of viruses. These samples are typically collected through swabbing, blood draws, or other methods. The collected samples are then analyzed in a laboratory setting to detect the presence of a virus. The results of these tests are used to diagnose and treat a variety of illnesses.
The Viral Specimen Collection market is driven by the increasing prevalence of viral diseases, the need for accurate and timely diagnosis, and the development of new technologies. The market is expected to continue to grow as new technologies are developed and more viruses are identified.
Some companies in the Viral Specimen Collection market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. Show Less Read more